Jing Cao, Ph.D. Titles and Appointments Associate Professor School Medical School Department Pathology Biography Dr. Jing Cao is board certified by the American Board of Clinical Chemistry. She directs Point of Care testing at Children's Health and Mass Spectrometry testing at Williams Clements Universtiy Hospital. Prior to joining the University of Texas Southwestern, she was an Assistant Professor at the Department of Pathology and Immunology at Baylor College of Medicine, and was the Associate Director of Clinical Chemistry at Texas Children’s Hospital. Dr. Cao's research focus has been on the clinical utility of lipoprotein biomarkers and related disparities in cardiovascular and metabolic dysfunction disease management. She is funded by the National Institute of Helath to study circulating biomarkers in neurological diseases. Education Medical School Anhui Medical University (2000) Internship The First Affiliated Hospital of Anhui Medical University (2001), Medicine Other Post Graduate Training University of Minnesota College of Biological Sciences (2006) Graduate School University of Minnesota College of Biological Sciences (2006) Other Post Graduate Training University of Minnesota College of Biological Sciences (2012) Graduate School University of Minnesota College of Biological Sciences (2012), Biochemistry, Molecular Biology & Biophysics Fellowship University of Minnesota Medical Center (2015), Clinical Chemistry Publications Featured Publications Factors associated with lipid lowering therapy in the multi-ethnic study of atherosclerosis. Cao J, Guan W, Nomura SO, Bhatia HS, Garg PK, Tsai MY, Lipids Health Dis 2024 Nov 23 1 375 Newborn Screening: Current Practice and Our Journey over the Last 60 Years. Cao J, Pasquali M, Jones PM, J Appl Lab Med 2024 Mar Poor Humoral Response in Solid Organ Transplant Recipients following Complete mRNA SARS-CoV-2 Vaccination. Cao J, Liu X, Muthukumar A, Gagan J, Jones P, Zu Y, Clin Chem 2021 Aug Liposome-mediated detection of SARS-CoV-2 RNA-positive extracellular vesicles in plasma. Ning B, Huang Z, Youngquist BM, Scott JW, Niu A, Bojanowski CM, Zwezdaryk KJ, Saba NS, Fan J, Yin XM, Cao J, Lyon CJ, Li CZ, Roy CJ, Hu TY, Nat Nanotechnol 2021 Jul Performance of novel low-density lipoprotein-cholesterol calculation methods in predicting clinical and subclinical atherosclerotic cardiovascular disease risk: The Multi-Ethnic Study of Atherosclerosis. Cao J, Remaley AT, Guan W, Devaraj S, Tsai MY, Atherosclerosis 2021 06 327 1-4 Apolipoprotein B discordance with low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in relation to coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis (MESA). Cao J, Nomura SO, Steffen BT, Guan W, Remaley AT, Karger AB, Ouyang P, Michos ED, Tsai MY, J Clin Lipidol 2020 Jan - Feb 14 1 109-121.e5 Perspectives on the Changing Landscape of Measuring Cardiovascular Risk Related to LDL. El-Khoury JM, Remaley AT, Nordestgaard BG, Kaufman HW, Mora S, Cao J, Meeusen JW, Clin. Chem. 2019 12 65 12 1487-1492 Evaluation of Lipoprotein(a) Electrophoretic and Immunoassay Methods in Discriminating Risk of Calcific Aortic Valve Disease and Incident Coronary Heart Disease: The Multi-Ethnic Study of Atherosclerosis. Cao J, Steffen BT, Guan W, Budoff M, Michos ED, Kizer JR, Post WS, Tsai MY, Clin. Chem. 2017 Nov 63 11 1705-1713 Clinical Features and Risk Stratification of Multiple Myeloma Patients with COVID-19. Zheng R, Mieth K, Bennett C, Miller C, Anderson LD, Chen M, Cao J, Cancers (Basel) 2023 Jul 15 14 Results 1-9 of 9 1 Professional Associations/Affiliations Academy of Diagnostics and Laboratory Medicine, formerly National Academy of Clinical Biochemistry (2016) Association of Diagnostics and Laboratory Medicine, formerly American Association of Clinical Chemistry (2004)
